OUR PEOPLE
Kirsten Bibbins-Domingo, PhD, MD, MAS
Professor
School of Medicine
Location Required
Education and Training
Princeton University, AB - 1987 Molecular Biology & Princeton School of Public and International Affairs
UCSF, Biochemistry, PhD - 1994 Biochemistry
UCSF, Medicine, MD - 1999 Medicine
UCSF, Medicine, Residency - 2001 Internal Medicine
UCSF, Epidemiology and Biostatistics, MAS - 2004 Masters in Clinical Research
University of California, San Francisco, CA 2020 Diversity, Equity, and Inclusion Champion Training
Awards and Honors
Elected to membership, American Society for Clinical Investigation, 2010
Lee Goldman, MD Endowed Chair in Medicine, UCSF, 2012
Mid-career Research Mentor Award, Society of General Internal Medicine, 2014
Elected to membership, National Academy of Medicine, 2015
Chancellor's Award for Public Service, UCSF, 2017
Elected to membership, Association of American Physicians, 2017
Ancel Keys Memorial Lecture, American Heart Association, 2017
Harold S. Luft Award for Mentoring in Health Services and Health Policy Research, UCSF Philip R. Lee Institute for Health Policy Studies, 2019
Distinguished Professor of Women and Medicine, Society of General Internal Medicine, 2019
Distinguished Citizen Award, Commonwealth Club of California, 2021
Beverlee A. Myers Award for Excellence in Public Health, California Department of Public Health, 2022
Elected to membership, American Academy of Arts and Sciences, 2022
Overview
Kirsten Bibbins-Domingo, PhD, MD, MAS is the Lee Goldman, MD Endowed Professor of Medicine and Professor of Epidemiology and Biostatistics. She is currently the 17th Editor in Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network.
Dr. Bibbins-Domingo has previously served as the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine. She also chaired the Department of Epidemiology and Biostatistics from 2017-2022. Dr. Bibbins-Domingo co-founded the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital that generates actionable research to increase health equity and reduce health disparities in at-risk populations in the San Francisco Bay Area, California, and nationally.
Dr. Bibbins-Domingo is a general internist, cardiovascular disease epidemiologist, and a national leader in prevention and interventions to address health disparities. She had been a long-standing NIH-funded researcher who used observational studies, pragmatic trials, and simulation modeling to examine effective clinical, public health, and policy interventions aimed at prevention.
Dr. Bibbins-Domingo was a member of the US Preventive Services Task Force from 2010-2017 and led the Task Force as the vice-chair and chair from 2014-2017. She is an inducted member of the American Society for Clinical Investigation, the Association of American Physicians, the National Academy of Medicine, and the American Academy of Arts and Sciences.
Dr. Bibbins-Domingo has previously served as the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine. She also chaired the Department of Epidemiology and Biostatistics from 2017-2022. Dr. Bibbins-Domingo co-founded the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital that generates actionable research to increase health equity and reduce health disparities in at-risk populations in the San Francisco Bay Area, California, and nationally.
Dr. Bibbins-Domingo is a general internist, cardiovascular disease epidemiologist, and a national leader in prevention and interventions to address health disparities. She had been a long-standing NIH-funded researcher who used observational studies, pragmatic trials, and simulation modeling to examine effective clinical, public health, and policy interventions aimed at prevention.
Dr. Bibbins-Domingo was a member of the US Preventive Services Task Force from 2010-2017 and led the Task Force as the vice-chair and chair from 2014-2017. She is an inducted member of the American Society for Clinical Investigation, the Association of American Physicians, the National Academy of Medicine, and the American Academy of Arts and Sciences.